"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said..
plemmons and co-authors disclosed no relevant relationships with industry.. fueled by low vaccination rates led to 9,000 sick children and 10 infant deaths..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...